AVDL
Avadel Pharmaceuticals
AVDL
AVDL
93 hedge funds and large institutions have $443M invested in Avadel Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
85% more capital invested
Capital invested by funds: $239M → $443M (+$203M)
24.24% more ownership
Funds ownership: 54.15% → 78.39% (+24%)
12% more funds holding
Funds holding: 83 → 93 (+10)
Holders
93
Holding in Top 10
7
Calls
$17.4M
Puts
$4.8M
Top Buyers
| 1 | +$51.4M | |
| 2 | +$16.1M | |
| 3 | +$11.6M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$9.23M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$6.87M |
Top Sellers
| 1 | -$2.93M | |
| 2 | -$1.93M | |
| 3 | -$1.86M | |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$1.07M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$988K |